Overview ABX Combined With Cisplatin Compared With Gemcitabine Combined With Cisplatin in NSCLC Status: Completed Trial end date: 2015-12-01 Target enrollment: Participant gender: Summary Assess the PFS/ORR/OS of ABX Combined With Cisplatin Compared With Gemcitabine Combined With Cisplatin in first Treatment of NSCLC Phase: Phase 2 Details Lead Sponsor: Fudan UniversityTreatments: CisplatinGemcitabine